BioNTech SE (BNTX)
103.76
+0.88
(+0.86%)
USD |
NASDAQ |
Sep 04, 16:00
103.76
0.00 (0.00%)
After-Hours: 20:00
BioNTech Cash and Short Term Investments (Annual) : 17.43B for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 17.43B |
| December 31, 2024 | 16.89B |
| December 31, 2023 | 12.88B |
| December 31, 2022 | 14.81B |
| December 31, 2021 | 1.925B |
| Date | Value |
|---|---|
| December 31, 2020 | 1.481B |
| December 31, 2019 | 582.74M |
| December 31, 2018 | 470.40M |
| December 31, 2017 | 206.66M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Moderna, Inc. | 5.80B |
| Biodexa Pharmaceuticals Plc | 11.48M |
| NuCana Plc | 32.62M |
| Mereo BioPharma Group Plc | 40.99M |
| MediGene AG | -- |